David R Epstein Axcella Health Inc. (AXLA) insider trading activity

AXLA Quotes by TradingView

David R Epstein is Director of Axcella Health Inc.. Currently has a direct ownership of 209,756 shares of AXLA, which is worth approximately $0. The most recent transaction as insider was on May 19, 2022, when has been sold 47,059 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 210K
0% 3M change
0% 12M change
Total Value Held $0

David R Epstein Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 19 2022
BUY
Grant, award, or other acquisition
-
47,059 Added 18.32%
209,756 Common Stock
Mar 18 2022
BUY
Exercise of conversion of derivative security
-
1,535 Added 0.93%
162,697 Common Stock
Mar 16 2022
BUY
Open market or private purchase
$50,000 $1.91 p/Share
26,178 Added 13.97%
161,162 Common Stock
Feb 18 2022
BUY
Exercise of conversion of derivative security
-
1,534 Added 1.12%
134,984 Common Stock
Jan 18 2022
BUY
Exercise of conversion of derivative security
-
1,535 Added 1.14%
133,450 Common Stock
Dec 17 2021
BUY
Exercise of conversion of derivative security
-
1,535 Added 1.15%
131,915 Common Stock
Nov 18 2021
BUY
Exercise of conversion of derivative security
-
1,534 Added 1.16%
130,380 Common Stock
Oct 18 2021
BUY
Exercise of conversion of derivative security
-
1,535 Added 1.18%
128,846 Common Stock
Sep 17 2021
BUY
Exercise of conversion of derivative security
-
1,535 Added 1.19%
127,311 Common Stock
Aug 18 2021
BUY
Exercise of conversion of derivative security
-
1,534 Added 1.2%
125,776 Common Stock
Jul 16 2021
BUY
Exercise of conversion of derivative security
-
1,535 Added 1.22%
124,242 Common Stock
Jun 18 2021
BUY
Exercise of conversion of derivative security
-
1,535 Added 1.24%
122,707 Common Stock
May 18 2021
BUY
Exercise of conversion of derivative security
-
1,534 Added 1.25%
121,172 Common Stock
Apr 18 2021
BUY
Exercise of conversion of derivative security
-
1,535 Added 1.27%
119,638 Common Stock

Also insider at

EVLO
Evelo Biosciences, Inc. Healthcare
Director
IFF
INTERNATIONAL FLAVORS & FRAGRANCES INC Basic Materials
Director
RUBY
Rubius Therapeutics, Inc. Healthcare
Director
SNTI
Senti Biosciences, Inc. Healthcare
Director
SGEN
Seagen Inc. Healthcare
CEO
TEM
Tempus AI, Inc.
DRE

David R Epstein

Director
South San Francisco, CA

Track Institutional and Insider Activities on AXLA

Follow Axcella Health Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXLA shares.

Notify only if

Insider Trading

Get notified when an Axcella Health Inc. insider buys or sells AXLA shares.

Notify only if

News

Receive news related to Axcella Health Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AXLA